July 20, 2021

UAMS Releases Findings from Statewide COVID-19 Antibody Study

David Robinson

A team at UAMS tested blood samples from July to December 2020 and found that by the end of the year, 7.4% of Arkansans had SARS-CoV-2 antibodies.

LITTLE ROCK — A statewide COVID-19 antibody study led by UAMS found that by the end of 2020, 7.4% of Arkansans had antibodies to the virus, but there were wide disparities among racial and ethnic groups. UAMS researchers released their findings this week to a public database, medRxiv (med archive).

July 14, 2021

NIH Awards $1.36 million Grant to Aid UAMS Research on Pregnant Women’s Pelvic Floor Muscles

Linda Satter

Hari Eswaran, Ph.D. ,shows off SARA, which he helped develop.

The National Institutes of Health has awarded a $1.36 million grant to researchers at UAMS to develop a non-invasive means of detecting weaknesses in a pregnant woman’s pelvic floor muscles that could lead to injury while giving birth.

July 9, 2021

UAMS Medical Student Published in JAMA Network Open

Linda Haymes

Austin Morgan, a third-year student in the College of Medicine, was recently published in JAMA Network Open, an international, peer-reviewed, open access, general medical journal that focuses on original research articles and commentary on a variety of medical and health topics.

The Journal of the American Medical Association (JAMA) recently published University of Arkansas for Medical Sciences (UAMS) medical student Austin Morgan’s results from his study on diversity among cancer centers’ leadership.

July 7, 2021

Researcher Finds Challenges in Study Involving Methamphetamine

Linda Haymes

Michael Wilson, M.D., an assistant professor of Emergency Medicine, is studying how methamphetamine affects the human body, particularly how the body responds to stress.

If the photo of the pile of crystal methamphetamine doesn’t get your attention, the question on the flyer, designed by the UAMS Translational Research Institute and complete with the UAMS logo and familiar triangles, will.

“Use meth?”

July 6, 2021

Winthrop P. Rockefeller Cancer Institute Hosts First Summer Research Intensive for Medical Students

Marty Trieschmann

The NIH-funded Partners in Cancer Research Program is underway at the Winthrop P. Rockefeller Cancer Institute. Second-year medical students learning clinical and in-depth cancer research this summer include (l to r) Nadia Safar, Anna Bragg, Pamela Rosales, Payton Smith, Carl Ramponi, Faizan Cheema, Tom Kelly, M.D. (associate director of Cancer Research and Training), Angel Castro, Robert Kiss, Delanie Mack, Sangeetha Sonney and Claire Keisling. Matthew Newman is not pictured.

New discoveries in cancer treatment might come from 24-year-old Nadia Safar, one of 12 UAMS medical students participating in the state’s first and only undergraduate cancer research program at the Winthrop P. Rockefeller Cancer Institute.  

July 1, 2021

UAMS Neurologist Co-Authors Best Practices Paper for Treating 2 Parkinson’s-related Disorders

Linda Satter

Rohit Dhall, M.D.

LITTLE ROCK — A neurologist at the University of Arkansas for Medical Sciences (UAMS) has co-authored a paper in a leading neurology journal that provides the first best-practices consensus for treating two rare Parkinson’s-related disorders. Rohit Dhall, M.D., a professor of neurology in the College of Medicine and director of neurodegenerative disorders at UAMS, was…

June 29, 2021

UAMS Physicians See Dramatic Increase In Postpartum Psychosis Cases during COVID-19 Pandemic

Tim Taylor

Jessica Coker, M.D., (left) and Erin Bider, M.D., collaborated on a paper detailing the rise in cases of postpartum psychosis they saw at UAMS' Women's Mental Health Program during the COVID-19 pandemic.

LITTLE ROCK — Postpartum psychosis is a serious, albeit rare illness, compared to the number of postpartum depression cases seen in the United States.

June 24, 2021

UAMS’ First Phase 1 Cancer Clinical Trial Testing New Way to Protect Hearts while Treating Cancer

David Robinson

UAMS' Hui-Ming Chang, M.D., is leading the Phoenix Trial.

LITTLE ROCK — The drug dexrazoxane has a reputation akin to someone who both fights and sets fires. On the one hand, this Food and Drug Administration (FDA)-approved drug prevents heart damage caused by doxorubicin, which is used in chemotherapy. On the other hand, dexrazoxane may undermine the cancer treatment, causing many doctors to leave…

June 14, 2021

UAMS Project Part of National Effort to Reduce COVID-19 in Hardest Hit Populations

David Robinson

A Marshallese resident in Northwest Arkansas receives a COVID-19 vaccine.

LITTLE ROCK — UAMS researchers and their community partners across Arkansas are studying the causes behind COVID-19’s devastating impact on minorities and developing plans to help increase vaccination rates.

June 4, 2021

Arkansas College Students Learn About COVID-19, Other Infectious Diseases at UAMS-led Workshop

David Robinson

Sumaira Sardar and Finn Beruldsen, students at Hendrix College, attended the Zoom-based infectious diseases career workshop.

UAMS treated Arkansas college students interested in research or medical careers involving infectious diseases like COVID-19 to a workshop May 19.

Previous page Next page